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Isothermal titration calorimetryIon pump, Na,K-ATPase specifically binds cardiotonic steroids (CTS), which leads to inhibition of the
enzyme activity and activation of signaling network in the cell. We have studied interaction of
Na,K-ATPase with CTS of two different types – marinobufagenin and ouabain. We have shown that
both CTS inhibit activity of Na,K-ATPase with the same Ki values, but binding of ouabain is sensitive
to the conformation of Na,K-ATPase while binding of marinobufagenin is not. Furthermore, binding
of ouabain and marinobufagenin results in different structural changes in Na,K-ATPase. Our data
allow to explain the diversity of effects on the receptor function of Na,K-ATPase caused by different
types of CTS.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Na,K-ATPase (NKA), an ubiquitous ion pump, provides active
transport of Na+ and K+ across plasma membrane in all types of
animal cells. During catalytic cycle the enzyme oscillates between
the two main conformations: E1, with high affinity to Na+ and ATP,
and E2, which has high affinity to K+ [1]. Resulting electrochemical
gradients of Na+ and K+ are used by other ions and nutrient trans-
porters for secondary active uptake of amino acids and glucose as
well as for maintenance of cellular pH and Ca2+ homeostasis, cell
volume and transmembrane potential.
NKA is specifically inhibited by cardiotonic steroids (CTS), and
the enzyme is the only known target for CTS. CTS that at first were
found in plants (cardenolides, among them the best known isouabain) and then in the skin of toads (bufadienolides) were later
discovered in the blood of vertebrates [2–5]. Endogenous ouabain
was the first CTS to be purified from human plasma [6]. It was
shown that ouabain binds to the NKA catalytic a subunit in the
E2 phosphorylated (E2P) conformation [7,8]. Later, another CTS
marinobufagenin (MBG) (3,5-dihydroxy-14,15-epoxy bufodieno-
lide) was detected in human plasma and urine [5,9,10]. Both CTS
act as potent vasoconstrictors [11] and increase of the MBG level
was observed in acute myocardial ischemia [5] and renal ischemia
[12]. CTS appear to be involved in the development of different
diseases including hypertension [13].
It was demonstrated that the NKA is a receptor selectively
responding to changes in the endogenous CTS level [14]. For exam-
ple, binding of ouabain to NKA leads to the activation of Src-kinase
and triggers signal cascades [14]. Presence of different CTS in the
organism presume their different effect on the NKA receptor func-
tion. Indeed, different CTS cause diverse quantitative as well as
qualitative biological responses [15]. It was shown that ouabain
and MBG at the same concentration inhibit ion transport by NKA
in renal epithelial cells by 50%. However they induce cell death
with different values of IC50 (about 0.05 and 5 lM, respectively)
[16]. Thus reduction of cell viability by CTS does not correlate with
the inhibitory effect of ouabain and MBG on the NKA activity and
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gered by the formation of CTS:NKA complexes. We hypothesized
that this can be a result of different structural changes in NKA
when it binds ouabain and MBG. In this study we have determined
the characteristics of ouabain and MBG binding with NKA and
assessed conformational changes in the enzyme when it forms
complexes with these CTS. We have shown that inhibition con-
stants of NKA by MBG and ouabain are close to each other and both
CTS bind to the same site in NKA. However ouabain is located dee-
per inside the NKA molecule compared to MBG, and binding of
ouabain is sensitive to the conformation of NKA while MBG bind-
ing is not. When forming complexes with NKA, ouabain and MBG
cause different structural changes in the enzyme molecule. Our
data allow to explain the diversity of effects on the receptor func-
tion of Na,K-ATPase caused by different types of CTS.
2. Materials and methods
2.1. Na,K-ATPase purification and activity measurements
Na,K-ATPase (a1b1 isozyme [17]) was purified from duck salt
glands (for details see [18–20]) to the purity grade of 95% of total
protein as confirmed by polyacrylamide gel electrophoresis in
the presence of SDS (Supplementary data, Fig. S1). The enzyme
preparations also contain a 13 kDa protein that is similar to pro-
teins of the FXYD family [21]. Protein concentration was deter-
mined by the method of Lowry with bovine serum albumin as a
standard. Hydrolytic activity of the duck NKA reached 1800–
2000 lmol Pi (mg protein  h)1 at 37 C.
Hydrolytic activity of the duck NKA was estimated as ATP cleav-
age in the medium containing (mM): 130 NaCl, 20 KCl, 3 MgCl2, 3
ATP, and 30 imidazole, pH 7.4 at 37 C as described elsewhere [22].
NKA concentration in the sample was 0.4–0.6 lg/ml. Dependence
of the NKA hydrolytic activity on CTS concentration was fitted by
the single logistic sigmoid function: Vi = Vmax/(1 + ([X]/Ki)n) [23],
where V is NKA hydrolytic activity, [X] is concentration of CTS, Ki
is inhibition constant and n is the Hill coefficient. Fitting was per-
formed using Origin 7.0 software (Microcal Software, Inc.).
2.2. Fluorescence measurements
Na,K-ATPase was labeled with fluorescein 5-isothiocyanate
(FITC) or with 5-iodoacetamidofluorescein (5-IAF) as described ear-
lier [24,25]. Stoichiometric ratio was equal to 0.5 mol FITC/1 mol
NKA and 0.5 mol 5-IAF/1 mol NKA. Fluorescence measurements
were carried out with 0.1 lM Na,K-ATPase, at 25 C in 10 mM imi-
dazole, 1 mM EDTA, 3 mM Pi/Tris, 3 mMMgCl2 pH 7.5, using Varian
Cary Eclipse fluorescence spectrophotometer. Excitation was at
495 nm, emission at 520 nm. The bandpass for the excitation light
and fluorescence were 5 nm, integration time was 0.1 s. Depen-
dence of NKA fluorescence level on the CTS concentrationwas fitted
by the single logistic sigmoid function [23]: F = Fmax/(1 + [X]/I50),
where F is fluorescence level, [X] is concentration of CTS, I50 is the
concentration of CTS causing 50% changes in the NKA fluorescence.
Fitting was performed using Origin 7.0 software.
2.3. Isothermal titration calorimetry (ITC)
The thermodynamic parameters of steroid binding to the duck
Na,K-ATPase were measured using MicroCal iTC200 instrument,
as described elsewhere [22,26]. Experiments were carried out at
25 C in three different solutions: (buffer 1) 10 mM imidazole,
1 mM EDTA, 0.1 mM DTT, 3 mM MgCl2, 3 mM Tris/Pi, pH 7.5; (buf-
fer 2) 10 mM imidazole, 1 mM EDTA, 0.1 mM DTT, 130 mM NaCl,
20 mM KCl, pH 7.5; (buffer 3) 10 mM imidazole, 1 mM EDTA,0.1 mM DTT, 3 mM NaCl, pH 7.5. Aliquots (2.6 ll) of ligands were
injected into a 0.2-ml cell containing protein solution to achieve
a complete binding isotherm. Protein concentration in the cell ran-
ged from 5 to 20 lM, and ligand concentration in the syringe ran-
ged from 50 to 200 lM. The resulting titration curves were fitted
using the MicroCal Origin software, assuming one set of binding
sites (for details see Supplementary data, Appendix). Affinity con-
stants (Ka) and enthalpy variations (DH) were determined and
the Gibbs energy (DG) and entropy variations (DS) were calculated
from the equation: DG = RTlnKa = DH  TDS.
Direct binding experiments were complemented by the dis-
placement titration calorimetry method determining an apparent
binding constant (Kapp) corresponding to the displacement of one
ligand by another. In this case, NKA was initially saturated with a
ligand L1 (MBG) introduced into the calorimeter cell and then
titrated with a ligand L2 (ouabain). An apparent binding constant,
corresponding to the displacement of L1 by L2, was thus deter-
mined. Then, knowing the binding constant K1 of L1, we deter-
mined the value of the binding constant K2 of L2 for NKA from
the equation K2 = Kapp(1 + K1[L1]) [27].
2.4. Modeling
Three-dimensional model of the NKA catalytic a subunit in
complex with MBG was created on the basis of the previously pub-
lished 3.4 Å structure of the porcine a subunit in complex with
ouabain (PDB code 4HYT) [28]. Sequence alignment of the duck
(Q7ZYV1 in the UniProtKB database) and pig (P05024) NKA a sub-
units by UNIPROT (www.uniprot.org) showed that the amino acid
residues involved in binding CTS are identical (Supplementary
data, Fig. S2). MBG was substituted for ouabain in the binding site
of the existing structure, with subsequent local energy minimiza-
tion of the complex structure (root mean square gradient: 0.05,
force field: MMFF94X, calculate forcefield partial charges: acti-
vated) after addition of hydrogens using the MOE version
2013.08 modeling software (Chemical Computing Group Inc.).
2.5. Chemicals and solutions
5-IAF and FITC were obtained from Molecular Probes, ouabain
and other reagents were purchased from Sigma, MBG was kindly
gifted by professor Bagrov (National Institute on Aging, National
Institutes of Health, Baltimore, MD). Ouabain was diluted in the
distilled water, stock solution of MBG was made using dimethyl
sulfoxide. The highest concentrations of dimethyl sulfoxide used
in the experiments (0.5%) did not affect neither enzyme activity,
nor the fluorescence of labeled enzyme.
3. Results
3.1. Inhibition of hydrolytic activity of Na,K-ATPase by CTS
Using purified NKA from duck salt gland we have found that
ouabain and MBG inhibited the hydrolytic activity of Na,K-
ATPase with similar inhibition constants (Ki) equal to 1.30 ± 0.08
and 0.57 ± 0.06 lM, respectively (Fig. 1A). The Hill coefficient value
(n) is close to 1 for both CTS, indicating the absence of cooperativ-
ity for the ouabain and MBG binding to NKA.
3.2. Changes in the labeled Na,K-ATPase fluorescence upon CTS binding
To examine conformational changes in the NKA alpha subunit
of a1b1 isozyme two fluorescent labels FITC and 5-IAF have been
used, which bind Lys501 and predominantly Cys457 of the alpha
subunit, respectively [29,30]. Both these residues are located in
Fig. 1. Effect of ouabain and marinobufagenin binding on the hydrolytic activity
and fluorescence intensity of Na,K-ATPase. (A) Inhibition of Na,K-ATPase hydrolytic
activity by ouabain (squares) and marinobufagenin (circles) at 37 C. (B and C)
Changes in fluorescence of 0.1 lM FITC-Na, K-ATPase (B) and 0.1 lM 5-IAF-Na,K-
ATPase (C) upon binding of ouabain and marinobufagenin at 25 C. Results of the
three independent experiments ± S.D. are presented.
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change in fluorescence of these labels reflected conformational
changes of NKA alpha subunit [29,30]. Addition of ouabain or
MBG to the FITC-labeled NKA in the presence of Mg2+ and Pi (E2P
conformation in which NKA has a maximal affinity to ouabain
[31]) leads to increase of the fluorescence level in the
concentration-dependent manner described by hyperbolic curves
(Fig. 1B). The maximum change in fluorescence intensity
(Fi  F0)/F0 * 100%, where F0 is initial fluorescence intensity, was
14% for ouabain and 25% for MBG (Fig. 1B).
Adding CTS to the NKA labeled with 5-IAF resulted in the
decrease of fluorescence intensity (Fig. 1C). As in the case of
FITC-labeled NKA, the change in fluorescence level was more pro-
nounced when 5-IAF-NKA interacted with MBG. The maximum flu-
orescence change constituted 3.7% for ouabain and 7.1% for MBG.
The difference between I50 values for binding of CTS with the
5-IAF and FITC labeled NKA can be explained by the fact that thelabels are localized in different microenvironments. Variations in
the labeled NKA fluorescence on binding MBG and ouabain point
to different structural changes resulting from binding these CTS.
3.3. Thermodynamics of ouabain and MBG binding to Na,K-ATPase
To ascertain differences in binding of ouabain and MBG to NKA
we used ITC, making it possible to determine thermodynamic
parameters of the interaction of biomolecules directly, without
labels and modification of the protein. Using ITC we estimated
association (Ka) and dissociation (Kd) equilibrium constants,
changes of enthalpy (DH) and entropy (DS) for the binding of oua-
bain and MBG to NKA in three states: E2P (buffer 1), E1/E2 (buffer
2) and E1 (buffer 3) (Table 1). A typical set of ITC data for the CTS
binding to NKA in E2P state at 25 C is shown in Fig. 2, including
the ‘‘raw” calorimetric data for the ligand-into-protein titration
(upper parts) and the binding curves (lower parts). The latter were
fitted to a model with one CTS binding site per NKA molecule.
In the E2P state, we observed a 17-fold higher affinity for the
binding of NKA to ouabain compared to MBG (Kd values equal to
0.1 and 1.7 lM, respectively) (Table 1). The obtained binding con-
stant for ouabain is close to the value determined previously [31].
As is clear from the thermodynamic parameters (Table 1), the bind-
ing of ouabain to NKA is an enthalpy-driven process. In contrast,
the MBG binding to NKA has a reduced enthalpic contribution
and a larger entropic component. ITC experiments were comple-
mented by ‘‘displacement titration”, where MBG was replaced in
the NKA-MBG binary complex by ouabain. The value of Kd
(0.08 lM) for ouabain binding to NKA estimated from a competi-
tive ligand binding model was virtually the same as those obtained
by the direct titration (Table 1). When titrating the NKA-ouabain
binary complex by MBG we did not detect any binding, which
can be explained by the fact that in the E2P conformation the bind-
ing constant of MBG and NKA is by order of magnitude lower than
the binding constant of ouabain (Table 1), and MBG cannot ‘‘dis-
place” it under given conditions (Table 1). Thus we can conclude
that both CTS bind to the same site of the protein.
In the E1/E2 state the affinity of NKA to ouabain decreased by an
order of magnitude in comparison to E2P state and binding chan-
ged from the enthalphy to entropy-favorable process (Table 1). In
the E1 state we could not detect binding of ouabain to NKA. At
the same time the affinity of MBG to NKA was practically the same
in all three states (Table 1), but thermodynamic profile of the bind-
ing process changed. Shift of NKA from the E2 to E1 state leads to
the reduction of entropy component and increase of enthalpy con-
tribution to binding.
3.4. Molecular modeling of the Na,K-ATPase structural changes upon
MBG binding
In the initial structure of the NKA:ouabain complex (PDB code
4HYT) ouabain forms five hydrogen bonds with the residues
Gln111, Glu117, Asn122, Glu312, Thr797 and six hydrophobic con-
tacts with the residues Leu125, Ile315, Phe316, Phe783, Phe786,
Leu793, located in the transmembrane helices M1, M2, M5 and
M6 in the enzyme alpha subunit (Fig. 3B) [7]. In the 4HYT structure
ouabain was replaced with MBG (Fig. 3C) with subsequent energy
minimization for the complex (Fig. 3D). In the energy-optimized
model, the steroid core of MBG is positioned by 5 Å closer to
the binding cavity entrance compared to ouabain (Fig. 3E and F).
In the complex with NKA, MBG forms one hydrogen bond with
Glu312 and five hydrophobic contacts with the same amino acids
as ouabain, Ile315, Phe316, Phe783, Phe786, and Leu793. However
interactions occur with different atoms of CTS (Fig. 3D). The NKA:
ouabain complex energy minimization did not lead to shifting of
the ouabain position in the binding site.
Table 1
Thermodynamic parameters of the duck Na,K-ATPase (NKA) binding to ouabain and marinobufagenin determined by isothermal titration calorimetry.
Sample NKA statea Ligand Kab (M1) Kdc (lM) DHd (kcal/mol) TDSe (kcal/mol) DGf (kcal/mol)
NKA E2P Ouabain 9.7  106 0.1 11.5 2.0 9.5
NKA E2P MBG 6.0  105 1.7 1.3 6.6 7.9
NKA-MBGg E2P Ouabain 11.9  106 0.08 9.7
NKA-ouabaing E2P MBG ndish ndis
NKA E1/E2 Ouabain 1.3  106 0.77 0.6 7.7 8.3
NKA E1/E2 MBG 6.5  105 1.5 2.9 5.0 7.9
NKA E1 Ouabain ndi nd
NKA E1 MBG 2.8  105 3.6 5.0 2.4 7.4
a The measurements of CTS binding to NKA in different states were performed in the three different solutions. E2P state: 10 mM imidazole, 0.1 mM DTT, 1 mM EDTA, 3 mM
MgCl2, 3 mM Tris/Pi, pH 7.5; E1/E2 state: 10 mM imidazole, 1 mM EDTA, 0.1 mM DTT, 130 mM NaCl, 20 mM KCl, pH 7.5; E1 state: 10 mM imidazole, 1 mM EDTA, 0.1 mM DTT,
3 mM NaCl, pH 7.5. All measurements were performed three to four times at 25 C.
b Ka – affinity constant; standard deviation did not exceed ±20%.
c Kd – dissociation constant; calculated as 1/Ka.
d DH – enthalpy variation; standard deviation did not exceed ±10%.
e TDS– entropy variation; calculated from the equation DG = DH  TDS.
f DG – Gibbs energy; calculated from the equation DG = RTlnKa.
g The model of competitive ligand binding was used (see Section 2).
h ndis – the displacement was not observed.
i nd – not detectable under the given experimental conditions. It means that the Ka value <1  105 M1.
Fig. 2. ITC data for ouabain (A) and marinobufagenin (B) binding to Na,K-ATPase (12 lM) in the E2P state. Titration curves (upper panel) and binding isotherms (lower panel)
are shown for the Na,K-ATPase interaction with ouabain and marinobufagenin at 25 C.
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Biological effects of CTS can be divided into the two major
groups – positive ionotropic effect which is associated with the
inhibition of NKA, and activation of specific signal transduction
pathways mediated by NKA. Circulating concentrations of endoge-
nous CTS (from a few nanomolar to picomolar) [2,13,32] are most
likely too low to induce inhibitory effect on the NKA ion transport.
The huge diversity in cardenolide and bufadienolide effects can be
attributed to different ability for activating specific transduction
pathways [33]. The latter might be a result of the fact that diverseCTS can induce the NKA conformations where the enzyme has dif-
ferent capacity to bind intracellular ligands such as Src-kinase,
BAX, Bcl-2, calveolin1, ankyrin, MLP and PI3-kinase [13,34–36].
We have shown that ouabain and MBG, while inhibiting the
NKA activity with similar Ki, induce changes in the fluorescence
of NKA conjugated with FITC and 5-IAF which have different mag-
nitude (Fig. 1B and C). According to the work of [24,37] changes in
the fluorescence of these labels reflect structural changes in NKA.
The Lys501 residue conjugated with FITC, is located in the
ATP-binding site of the nucleotide binding domain (Fig. 4). In
the NKA molecule 5-IAF bonded with Cys457 [30] is located in
Fig. 3. Location of ouabain and marinobufagenin in the structure of Na,K-ATPase. (A) Chemical structure of ouabain and (B) its binding site in the structure of the Na,K-
ATPase:ouabain complex (PDB code 4HYT). Amino acid residues of NKA involved in the complex formation are indicated. Hydrogen bonds between the cardiotonic steroids
and Na,K-ATPase are shown by dotted lines. (C) Chemical structure of marinobufagenin. (D) Modeling of the marinobufagenin binding site in Na,K-ATPase based on the
structure of NKA:ouabain complex (PDB code 4HYT). (E) Superposition of ouabain (cyan) and marinobufagenin (magenta) in the binding site of Na,K-ATPase. The distance
between ouabain and marinobufagenin C17 atoms is 5.1 Å. (F) Superposition of the complexes Na,K-ATPase:ouabain and Na,K-ATPase:marinobufagenin. The structural
elements of Na,K-ATPase in the complex with marinobufagenin are shown in magenta and in the complex with ouabain in gray. M1, M2, M3, M4 and M5 are transmembrane
segments of the Na,K-ATPase alpha subunit.
Fig. 4. Cartoon representation of the Na,K-ATPase:ouabain complex (PDB code
4HYT). Ouabain is represented by magenta sticks, aM5 is marked in red, Lys501 and
Cys457 are shown as ball-and-stick representation with standard color coding for
atom types (carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow; phosphorus,
pink; magnesium, brown).
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ATP-binding site. According to our data, binding of ouabain and
MBG to NKA leads to the FITC fluorescence increase, and decreasein the 5-IAF fluorescence, more pronounced for MBG (Fig. 1B and
C). These data suggest that binding of both CTS shifts the confor-
mation of NKA from the E2P state, and MBG produces more signif-
icant structural changes than ouabain.
Crystallographic data show that the ouabain binding site is
located in the cavity formed by the transmembrane segments of
the NKA alpha subunit (Figs. 3F and 4) [7]. There it forms six
hydrophobic contacts and five hydrogen bonds with NKA. Our data
show that MBG binds in the same cavity though it forms only a sin-
gle hydrogen bond and five hydrophobic contacts with NKA
(Fig. 3D). The MBG molecule is positioned by 5 Å closer to the
cavity entrance than ouabain. The deformation of the cavity as a
result of conformational changes in the molecule will impair NKA
binding with the relevant CTS. Apparently, this causes a decrease in
ouabain affinity to NKA with its transition to the E1 state (Table 1).
The fact that MBG is buried relatively less deep in the binding cav-
ity explains lower dependence of MBG affinity to conformational
changes in the NKA molecule.
Molecular modeling results show that ouabain and MBG bind-
ing result in different positioning of the NKA transmembrane seg-
ments forming the binding site (Fig. 3F), which consequently
causes a range of structural changes in the cytosolic part of the
molecule. These changes may be conveyed to the cytosolic part
of the molecule mainly via interaction of CTS with the most
extended transmembrane segment aM5 reaching the nucleotide
binding domain (Fig. 4).
It is believed that NKA in the E2P state has the highest affinity to
ouabain [7]. Thus other CTS binding assays are usually carried out
under the same conditions [8,31]. According to our ITC data affinity
of MBG shows week dependence on the NKA state (E2P or E1),
while the ouabain affinity to NKA dramatically decreases in E1
state (Table 1). However the inhibition constants of NKA hydrolytic
activity by MBG and ouabain are similar. Hence when the enzyme
oscillates between the E2 and E1 states, its affinity for various CTS
becomes essentially the same. This is confirmed by our results on
the NKA binding with CTS when the enzyme is in the intermediate
state (E1/E2) (Table 1). These results explain the effect of divergent
values of the binding affinity and inhibitory potency, which was
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et al. [38]. We believe that these differences occur due to the sen-
sitivity of CTS to conformational changes in NKA.
Decline of the enzyme activity under conditions of oxidative
stress or low ATP levels, will facilitate ouabain binding that is sen-
sitive to changes in the enzyme conformation. Indeed, the increase
in sensitivity to ouabain of the failing human myocardium was
linked, among other factors to decreased activity of the sarcolem-
mal NKA [39]. Our data show that the efficiency of MBG binding
depends largely on its concentration rather than the enzyme
conformation. This concurs with the observation that a range of
pathological conditions, namely myocardial infarction, chronic kid-
ney disease, renal ischemia and preeclampsia are accompanied by
changes in the concentration of MBG [5,12,32,40,41]. It can be
conjectured that MBG binding resulting in the decrease of NKA
activity, increases the efficiency of ouabain binding, which can
therefore serve as the MBG modulator. At present it is known
that ouabain binding can reduce the toxicity of other CTS [42],
possibly due to the activation of anti-apoptotic cascades [43].
Consequently different sensitivity of the CTS binding to NKA
conformation may be important for their function.
As shown by our data ouabain and MBG affect the NKA confor-
mation in a different way, which in turn may support binding of
various proteins to the enzyme. At present NKA is known to bind
over 10 proteins. For some of these it was shown that this binding
is regulated by ouabain [35]. It is possible that CTS binding might
not only trigger signaling cascades, but alter the NKA sensitivity
to the regulatory proteins such as PKC, BAX, and Bcl-2 affecting
the enzyme activity and regulating its presence in the membrane
[34].
The effectiveness of protein binding with NKA can change
depending on a range of factors. Some of the proteins (e.g. PI3-
kinase, caveolin, ankyrin and proapoptotic Bcl-2 proteins) have
overlapping binding sites located at or near the NKA actuator
domain [34,44–46] and therefore cannot bind simultaneously. Pos-
sibly protein binding with the actuator domain occurs after the
enzyme inhibition by CTS and its conformational rearrangements
leading to a better access for the relevant proteins to the binding
site located in the Na,K-ATPase alpha subunit. Binding of NKA with
ouabain and MGB stabilizes a range of the NKA conformations pos-
sibly supporting different receptor functions of the enzyme.
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